• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血浆置换在肺和胸膜化脓性破坏性疾病患者联合治疗中的应用]

[Plasmapheresis in the combination therapy of patients with pyogenic destructive diseases of the lungs and pleura].

作者信息

Alekseeva M E, Pavliutenkov M G, Daberkha M

出版信息

Grudn Khir. 1989 Jan-Feb(1):59-62.

PMID:2925111
Abstract

Plasmapheresis is an effective method for controlling the resorption factor in patients with pyogenic destructive diseases of the lungs and pleura. It facilitates rapid normalization of the parameters of the patients' clinical condition and the radiological picture, and reduces endogenous intoxication. Protein-volemic disorders are more manifest in patients with a fatal outcome, which increase with the gradual progression of the disease and must be corrected before performing plasmapheresis.

摘要

血浆置换是控制肺和胸膜化脓性破坏性疾病患者吸收因子的有效方法。它有助于患者临床状况参数和放射学影像迅速恢复正常,并减轻内源性中毒。蛋白容量紊乱在预后不良的患者中更为明显,且随疾病的逐渐进展而加重,在进行血浆置换前必须予以纠正。

相似文献

1
[Plasmapheresis in the combination therapy of patients with pyogenic destructive diseases of the lungs and pleura].[血浆置换在肺和胸膜化脓性破坏性疾病患者联合治疗中的应用]
Grudn Khir. 1989 Jan-Feb(1):59-62.
2
[Liver and kidney functions after therapeutic plasmaphereses in the treatment of acute destructive diseases of the lungs and pleura].[治疗性血浆置换治疗急性肺和胸膜破坏性疾病后的肝肾功能]
Fiziol Cheloveka. 2006 Jan-Feb;32(1):115-7.
3
[Therapeutic plasmapheresis and extracorporeal low-flow blood oxygenation in the combined treatment of patients with acute suppurative-septic lesions of the lungs and pleura].[治疗性血浆置换和体外低流量血液氧合在急性肺和胸膜化脓性感染患者联合治疗中的应用]
Vestn Khir Im I I Grek. 1993 Jan-Feb;150(1-2):86-90.
4
[Dynamics of volemic parameters in patients with pyo-destructive pulmonary and pleural diseases in various types of substitution of removed plasma in the process of plasmapheresis].[血浆置换过程中不同类型去除血浆替代物时,脓性破坏性肺和胸膜疾病患者容量参数的动态变化]
Gematol Transfuziol. 1992 Apr;37(4):29.
5
[Effect of hemosorption on immunological reactivity indices in the combined treatment of patients with extensive nonspecific destructive suppurative processes in the lungs and pleura].[血液吸附对肺部和胸膜广泛非特异性破坏性化脓性病变患者联合治疗中免疫反应指标的影响]
Grudn Khir. 1985 Mar-Apr(2):20-3.
6
[Use of low frequency ultrasonic technology in preventing and treating purulent wounds of the lung and pleura].[低频超声技术在防治肺和胸膜化脓性伤口中的应用]
Khirurgiia (Mosk). 2002(5):64-7.
7
[Strategy of treatment of patients with acute purulent diseases of the lungs with bronchopleural fistulas, pyopneumothorax].[伴有支气管胸膜瘘、脓气胸的急性肺部化脓性疾病患者的治疗策略]
Vestn Khir Im I I Grek. 2001;160(3):86-8.
8
[The use of bronchological methods as the means for the intensive treatment of patients with severe manifestations of lung and pleural diseases].[使用支气管学方法作为对伴有肺部和胸膜疾病严重表现患者进行强化治疗的手段]
Probl Tuberk. 1989(12):25-8.
9
[Surgical treatment of acute suppurative destructive lesions of the lungs and pleura in sepsis].
Vestn Khir Im I I Grek. 1979 Jul;123(7):13-7.
10
[Supplemental parenteral feeding after operations in suppurative diseases of the lungs and pleura].[肺部及胸膜化脓性疾病手术后的胃肠外补充营养]
Grudn Khir. 1981 Jan-Feb(1):67-70.